T follicular helper (TFH) cells in normal and dysregulated immune responses

Annual Review of Immunology

Volumn 26, Issue , 2008, Pages 741-766

  King, Cecile ^a   Tangye, Stuart G ^a   Mackay, Charles R ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Antibodies; Autoimmunity; Chemokines; IL 21; Immunodeficiency; T cell help

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; PROTEIN BCL 6; TRANSCRIPTION FACTOR GATA 3;

ANTIBODY PRODUCING CELL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOID TISSUE; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; GERMINAL CENTER; HUMANS; IMMUNE SYSTEM DISEASES; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 41549131849     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.26.021607.090344     Document Type: Review

References (163)

1. Claman HN, Chaperon EA, Triplett RF. 1966. Thymus-marrow cell combinations: synergism in antibody production. Proc. Soc. Exp. Biol. Med. 122:1167-71
2. Miller JF, Mitchell GF. 1968. Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J. Exp. Med. 128:801-20
3. MacLennan IC. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-39
4. Hess J, Laumen H, Muller KB, Wirth T. 1998. Molecular genetics of the germinal center reaction. J. Cell. Physiol. 177:525-34
5. Kelsoe G. 1995. In situ studies of the germinal center reaction. Adv. Immunol. 60:267-88
6. Liu YJ, Malisan F, de Bouteiller O, Guret C, Lebecque S, et al. 1996. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 4:241-50
7. Liu YJ, Banchereau J. 1996. The paths and molecular controls of peripheral B-cell development. The Immunologist 4:55-66
8. Manz RA, Hauser AE, Hiepe F, Radbruch A. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23:367-86
9. van Kooten C, Banchereau J. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67:2-17
10. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, et al. 1999. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 397:263-66
11. Spolski R, Leonard WJ. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26:57-79
12. Leonard WJ, Spolski R. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688-98
13. Forster R, Mattis MJJ, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-47
14. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803
15. Cyster JG, Ansel KM, Reif K, Ekland EH, Hyman PL, et al. 2000. Follicular stromal cells and lymphocyte homing to follicles. Immunol. Rev. 176:181-93
16. Forster R, Emrich T, Kremmer E, Lipp M. 1994. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 84:830-40
17. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192:1553-62
18. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-52
19. Mackay CR. 2000. Follicular homing T helper (Th) cells and the Th1/Th2 paradigm. J. Exp. Med. 192:F31-34
20. + T cells. J. Exp. Med. 193:1373-81
21. + T follicular helper cells. J. Immunol. 179:8180-90
22. Abbas AK, Urioste S, Collins TL, Boom WH. 1990. Heterogeneity of helper/inducer T lymphocytes. IV. Stimulation of resting and activated B cells by Th1 and Th2 clones. J. Immunol. 144:2031-37
23. Kopf M, Le Gros G, Coyle AJ, Kosco-Vilbois M, Brombacher F. 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148:45-69
24. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-33
25. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
26. Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P. 1998. CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1 J. Exp. Med. 188:297-304
27. Brocker T, Gulbranson-Judge A, Flynn S, Riedinger M, Raykundalia C, Lane P. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29:1610-16
28. Walker LS, Gulbranson-Judge A, Flynn S, Brocker T, Raykundalia C, et al. 1999. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190:1115-22
29. +CD4 germinal center Th cells. J. Immunol. 177:4927-32
30. + follicular B helper T cell maintenance in vivo. J. Immunol. 175:2340-48
31. Moser B, Ebert L. 2003. Lymphocyte traffic control by chemokines: follicular B helper T cells. Immunol. Lett. 85:105-12
32. H2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13:139-45
33. Linton PJ, Harbertson J, Bradley LM. 2000. A critical role for B cells in the development of memory CD4 cells. J. Immunol. 165:5558-65
34. Tsitoura DC, Yeung VP, DeKruyff RH, Umetsu DT. 2002. Critical role of B cells in the development of T cell tolerance to aeroallergens. Int. Immunol. 14:659-67
35. Stockinger B, Zal T, Zal A, Gray D. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891-99
36. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, et al. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475-82
37. + T cells. Eur. J. Immunol. 34:3562-71
38. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, et al. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475-82
39. Johansson-Lindbom B, Borrebaeck CA. 2002. Germinal center B cells constitute a predominant physiological source of IL-4: implication for Th2 development in vivo. J. Immunol. 168:3165-72
40. - accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 18:643-54
41. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204(8):1849-61
42. Vinuesa CG, Tangye SG, Moser B, Mackay CR. 2005. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5:853-65
43. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, et al. 2007. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178:2827-34
44. H17 cells. Nature 448:484-87
45. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, et al. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480-83
46. + T cells defines terminally differentiated B cell-helping effector T cells in a B cell-rich lymphoid tissue. J. Immunol. 179:7448-56
47. Gulino AV, Notarangelo LD. 2003. Hyper IgM syndromes. Curr. Opin. Rheumatol. 15:422-29
48. Mak TW, Shahinian A, Yoshinaga SK, Wakeham A, Boucher LM, et al. 2003. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4:765-72
49. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, et al. 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4:261-68
50. Grimbacher B, Warnatz K, Peter HH. 2003. The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity. Curr. Opin. Allergy Clin. Immunol. 3:409-19
51. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, et al. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173:68-78
52. Kim CH, Lim HW, Kim JR, Rott L, Hillsamer P, Butcher EC. 2004. Unique gene expression program of human germinal center T helper cells. Blood 104:1952-60
53. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, et al. 2005. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452-58
54. hi CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 36:1892-903
55. Ho IC, Glimcher LH. 2002. Transcription: tantalizing times for T cells. Cell 109(Suppl.):S109-20
56. Weaver CT, Hatton RD, Mangan PR, Harrington LE. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25:821-52
57. + T helper cells. Cell 126:1121-33
58. Mlman D, Jain A, Dent A, Maile RR, Selvaggi T, et al. 1996. BCL-6 expression during B-cell activation. Blood 87:5257-68
59. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, et al. 1995. BCL-6 protein is expressed in germinal-center B cells. Blood 86:45-53
60. Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, et al. 1995. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86:18-37
61. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212
62. Dent AL, Shaffer AL, Yu X, Mlman D, Staudt LM. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-92
63. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, et al. 1997. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16:161-70
64. Kusam S, Toney LM, Sato H, Dent AL. 2003. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6. J. Immunol. 170:2435-41
65. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Suzumiya J, Go JH. 1999. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum. Pathol. 30:403-11
66. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, et al. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890-93
67. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-52
68. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197:181-93
69. Warnatz K, Bossaller L, Salzer U, Skrabl-Baumgartner A, Schwinger W, et al. 2006. Human ICOS-deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107:3045-52
70. + T cells. J. Clin. Investig. 115:1049-59
71. Liang L, Porter EM, Sha WC. 2002. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J. Exp. Med. 196:97-108
72. Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, et al. 2000. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164:4689-96
73. Diehn M, Mizadeh AA, Rando OJ, Liu CL, Stankunas K, et al. 2002. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 99:11796-801
74. Riley JL, Mao M, Kobayashi S, Biery M, Burchard J, et al. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99:11790-95
75. Acuto O, Michel F. 2003. CD28-mediated costimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3:939-51
76. Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O. 2001. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15:935-45
77. Sharpe AH, Freeman GJ. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-26
78. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, et al. 2000. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13:95-105
79. Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, et al. 2001. ICOS costimulatory receptor is essential for T-cell activation and function. Nature 409:97-101
80. Dong C, Temann UA, Flavell RA. 2001. Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166:3659-62
81. Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409:105-9
82. hi CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 36:1892-903
83. + germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination. BMC Immunol. 6:3
84. + memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 181:1293-301
85. Bowen MB, Butch AW, Parvin CA, Levine A, Nahm MH. 1991. Germinal center T cells are distinct helper-inducer T cells. Hum. Immunol. 31:67-75
86. + cells with natural killer cell-related features. Divergence from typical T helper cells. J. Immunol. 137:2808-13
87. + GC-derived helper T cells in vitro requires addition of exogenous IL-2. Cell. Immunol. 169:166-73
88. Johansson-Lindbom B, Ingvarsson S, Borrebaeck CA. 2003. Germinal centers regulate human Th2 development. J. Immunol. 171:1657-66
89. + T cells derived from peripheral blood do not support immunoglobulin production by B cells. Cell. Immunol. 163:245-53
90. + T cells act differently on B cells than do classical T-helper cells. Dev. Immunol. 4:189-97
91. + germinal-center cells with the T helper-cell phenotype and granular lymphocyte morphology. J. Clin. Immunol. 6:205-15
92. + T cells. J. Immunol. 178:5010-17
93. Butch AW, Chung GH, Hoffmann JW, Nahm MH. 1993. Cytokine expression by germinal center cells. J. Immunol. 150:39-47
94. Toellner KM, Scheel-Toellner D, Sprenger R, Duchrow M, Trumper LH, et al. 1995. The human germinal centre cells, follicular dendritic cells and germinal centre T cells produce B cell-stimulating cytokines. Cytokine 7:344-54
95. Marinova E, Han S, Zheng B. 2006. Human germinal center T cells are unique Th cells with high propensity for apoptosis induction. Int. Immunol. 18:1337-45
96. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57-63
97. Parrish-Novak J, Foster DC, Holly RD, Clegg CH. 2002. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J. Leukoc. Biol. 72:856-63
98. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. 2000. Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc. Natl. Acad. Sci. USA 97:11439-44
99. Ueda M, Imada K, Imura A, Koga H, Hishizawa M, Uchiyama T. 2005. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br. J. Haematol. 128:169-76
100. Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, et al. 2001. Cutting edge: the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167:1-5
101. Leonard WJ. 2001. Cytokines and immunodeficiency diseases. Nat. Rev. Immunol. 1:200-8
102. Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, et al. 2002. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16:559-69
103. + T lymphocytes. J. Immunol. 178:732-39
104. Zeng R, Spolski R, Casas E, Zhu W, Levy DE, Leonard WJ. 2007. The molecular basis of IL-21-mediated proliferation. Blood 109:4135-42
105. Fröhlich A, Marsland BJ, Sonderegger I, Kurrer M, Hodge MR, et al. 2007. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109:2023-31
106. Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, et al. 2002. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells. J. Exp. Med. 196:969-77
107. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF Jr, et al. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Investig. 116:2044-55
108. Jin H, Carrio R, Yu A, Malek TR. 2004. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173:657-65
109. Good KL, Bryant VL, Tangye SG. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21 J. Immunol. 177:5236-47
110. Ettinger R, Sims GP, Fairhurst AM, Robbins R, da Silva YS, et al. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175:7867-79
111. Mehta DS, Wurster AL, Whitters MJ, Young DA, Collins M, Grusby MJ. 2003. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170:4111-18
112. Jin H, Malek TR. 2006. Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21. J. Leukoc. Biol. 80:1416-23
113. Pene J, Gauchat JF, Lecart S, Drouet E, Guglielmi P, et al. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172:5154-57
114. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173:5361-71
115. Pene J, Guglielmi L, Gauchat JF, Harrer N, Woisetschlager M, et al. 2006. IFN-γ-mediated inhibition of human IgE synthesis by IL-21 is associated with a polymorphism in the IL-21R gene. J. Immunol. 177:5006-13
116. Suto A, Nakajima H, Hirose K, Suzuki K, Kagami S, et al. 2002. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4-stimulated B cells. Blood 100:4565-73
117. Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, et al. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298:1630-34
118. Shang XZ, Ma KY, Radewonuk J, Li J, Song XY, et al. 2006. IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-γ-deficient mice in a Th2-biased response. Cell. Immunol. 241:66-74
119. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967-74
120. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-46
121. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, et al. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309-14
122. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, et al. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29:2037-45
123. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. 1999. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190:1123-34
124. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281:96-99
125. Gulbranson-Judge A, MacLennan I. 1996. Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c. Eur. J. Immunol. 26:1830-37
126. Fuller KA, Kanagawa O, Nahm MH. 1993. T cells within germinal centers are specific for the immunizing antigen. J. Immunol. 151:4505-12
127. Fazilleau N, Eisenbraun MD, Malherbe L, Ebright JN, Pogue-Caley RR, et al. 2007. Lymphoid reservoirs of antigen-specific memory T helper cells. Nat. Immunol. 8:753-61
128. Fazilleau N, McHeyzer-Williams LJ, McHeyzer-Williams MG. 2007. Local development of effector and memory T helper cells. Curr. Opin. Immunol. 19:259-67
129. Wen L, Pao W, Wong FS, Peng Q, Craft J, et al. 1996. Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non α/β" T cells. J. Exp. Med. 183:2271-82
130. Caccamo N, Battistini L, Bonneville M, Poccia F, Fournie JJ, et al. 2006. CXCR5 identifies a subset of Vγ9Vδ2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. J. Immunol. 177:5290-95
131. Brandes M, Willimann K, Lang AB, Nam KH, Jin C, et al. 2003. Flexible migration program regulates γδ T-cell involvement in humoral immunity. Blood 102:3693-701
132. Vermijlen D, Ellis P, Langford C, Klein A, Engel R, et al. 2007. Distinct cytokine-driven responses of activated blood γδ T cells: insights into unconventional T cell pleiotropy. J. Immunol. 178:4304-14
133. Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, et al. 2001. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J. Clin. Investig. 108:1061-70
134. Luzina IG, Atamas SP, Storrer CE, daSilva LC, Kelsoe G, et al. 2001. Spontaneous formation of germinal centers in autoimmune mice. J. Leukoc. Biol. 70:578-84
135. Grammer AC, Slota R, Fischer R, Gur H, Girschick H, et al. 2003. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Investig. 112:1506-20
136. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103:9970-75
137. Hutloff A, Buchner K, Reiter K, Baelde HJ, Odendahl M, et al. 2004. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50:3211-20
138. Iwai H, Abe M, Hirose S, Tsushima F, Tezuka K, et al. 2003. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol. 171:2848-54
139. Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, et al. 2007. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 56:1152-63
140. Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178:3822-30
141. Mackay IR, Burnet FM. 1963. Autoimmune Diseases. Pathogenesis, Chemistry and Therapy. Springfield, IL: Charles C. Thomas
142. Weyand CM, Goronzy JJ. 2003. Ectopic germinal center formation in rheumatoid synovitis. Ann. NY Acad Sci. 987:140-49
143. Drayton DL, Liao S, Mounzer RH, Ruddle NH. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7:344-53
144. Lee Y, Chin RK, Christiansen P, Sun Y, Tumanov AV, et al. 2006. Recruitment and activation of naive T cells in the islets by lymphotoxin β receptor-dependent tertiary lymphoid structure. Immunity 25:499-509
145. Kendall PL, Yu G, Woodward EJ, Thomas JW. 2007. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes. J. Immunol. 178:5643-51
146. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. 1999. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190:1123-34
147. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, et al. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167:1072-80
148. Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, et al. 2001. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J. Immunol. 166:650-55
149. Lim HW, Hillsamer P, Kim CH. 2004. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J. Clin. Investig. 114:1640-49
150. Yu D, Tan AH-M, Hu X, Athanasopoulos V, Simpson N, et al. 2007. Roquin represses autoimmunity by limiting inducible T cell costimulator messenger mRNA. Nature 450:299-303
151. Notarangelo LD, Giliani S, Mazzolari E, Gulino AV. 2003. Primary immune deficiencies unravel the molecular basis of immune response. Rev. Clin. Exp. Hematol. 7:84-111
152. Ma CS, Nichols KE, Tangye SG. 2007. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25:337-79
153. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, et al. 1994. Mice deficient for the CD40 ligand. Immunity 1:423-31
154. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, et al. 2001. ICOS is critical for CD40-mediated antibody class switching. Nature 409:102-5
155. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. 2003. SAP is required for generating long-term humoral immunity. Nature 421:282-87
156. Cannons JL, Yu LJ, Jankovic D, Crotty S, Horai R, et al. 2006. SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation. J. Exp. Med. 203:1551-65
157. + phenotype. Am. J. Surg. Pathol. 25:395-400
158. FH). Blood 109:4952-63
159. Krenacs L, Schaerli P, Kis G, Bagdi E. 2006. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood 108:1110-11
160. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. 2006. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 30:802-10
161. Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A, et al. 2006. Expression of CXCL13 b neoplastic cells in angioimmunoblastic T-cell lymphoma (MTL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am. J. Surg. Pathol. 30:490-94
162. Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. 2005. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood 106:1501-2
163. Dogan A, Attygalle AD, Kyriakou C. 2003. Angioimmunoblastic T-cell lymphoma. Br. J. Haematol. 121:681-91